Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Kidney transplant from uncontrolled donation after circulatory death donors maintained by nECMO has long-term outcomes comparable to standard criteria donation after brain death.
Molina M, Guerrero-Ramos F, Fernández-Ruiz M, González E, Cabrera J, Morales E, Gutierrez E, Hernández E, Polanco N, Hernández A, Praga M, Rodriguez-Antolín A, Pamplona M, de la Rosa F, Cavero T, Chico M, Villar A, Justo I, Andrés A. Molina M, et al. Am J Transplant. 2019 Feb;19(2):434-447. doi: 10.1111/ajt.14991. Epub 2018 Aug 16. Am J Transplant. 2019. PMID: 29947163 Free article. Clinical Trial.
Reply by Authors.
Tyson MD, Morris D, Palou J, Rodriguez O, Mir MC, Dickstein RJ, Guerrero-Ramos F, Scarpato KR, Hafron JM, Messing EM, Cutie CJ, Maffeo JC, Raybold B, Chau A, Stromberg KA, Keegan KA. Tyson MD, et al. J Urol. 2023 May;209(5):900. doi: 10.1097/JU.0000000000003195.02. Epub 2023 Apr 7. J Urol. 2023. PMID: 37026638 No abstract available.
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics.
Subiela JD, Krajewski W, González-Padilla DA, Laszkiewicz J, Taborda J, Aumatell J, Sanchez Encinas M, Basile G, Moschini M, Caño-Velasco J, Lopez Perez E, Del Olmo Durán P, Gallioli A, Tukiendorf A, D'Andrea D, Yuen-Chun Teoh J, Serna Céspedes A, Pichler R, Afferi L, Del Giudice F, Gomez Rivas J, Albisinni S, Soria F, Ploussard G, Mertens LS, Rajwa P, Laukhtina E, Pradere B, Tully K, Guerrero-Ramos F, Rodríguez-Faba Ó, Alvarez-Maestro M, Dominguez-Escrig JL, Szydełko T, Gomez Dos Santos V, Jiménez Cidre MÁ, Burgos Revilla FJ; European Association of Urology-Young Academic Urologists EAU-YAU: Urothelial Carcinoma Working Group. Subiela JD, et al. Among authors: guerrero ramos f. Eur Urol Oncol. 2024 Dec;7(6):1367-1375. doi: 10.1016/j.euo.2024.01.017. Epub 2024 Feb 13. Eur Urol Oncol. 2024. PMID: 38355375
Clinical Usefulness of Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography for the Detection of Prostate Cancer Biochemical Recurrence after Primary Radiation Therapy in Patients with Prostate-specific Antigen Below the Phoenix Threshold: Systematic Review and Meta-analysis.
Subiela JD, Gomis Sellés E, Maldonado A, Lopez Campos F, Aumatell Ovide J, Ajuria Illarramendi O, González-Padilla DA, Gajate P, Ortega Polledo LE, Alonso Y Gregorio S, Guerrero-Ramos F, Gómez Dos Santos V, Rodríguez-Patrón R, Calais J, Kishan AU, Burgos Revilla FJ, Couñago F. Subiela JD, et al. Clin Oncol (R Coll Radiol). 2023 Dec;35(12):e676-e688. doi: 10.1016/j.clon.2023.09.012. Epub 2023 Sep 27. Clin Oncol (R Coll Radiol). 2023. PMID: 37802722
Safety, Tolerability, and Preliminary Efficacy of TAR-200 in Patients With Muscle-invasive Bladder Cancer Who Refused or Were Unfit for Curative-intent Therapy: A Phase 1 Study.
Tyson MD, Morris D, Palou J, Rodriguez O, Mir MC, Dickstein RJ, Guerrero-Ramos F, Scarpato KR, Hafron JM, Messing EM, Cutie CJ, Maffeo JC, Raybold B, Chau A, Stromberg KA, Keegan KA. Tyson MD, et al. J Urol. 2023 May;209(5):890-900. doi: 10.1097/JU.0000000000003195. Epub 2023 Apr 7. J Urol. 2023. PMID: 37026631 Clinical Trial.
Consensus document on the implications of standardization of BCG supply in the management of patients with non-muscle-invasive bladder cancer.
Rodríguez Faba Ó, Fernández Gómez JM, Guerrero-Ramos F, Álvarez-Maestro M, Ledo Cepero MJ, Unda Urzaiz M, Martínez-Piñeiro L, Cózar Olmo JM, Redorta JP, Álvarez-Ossorio JL. Rodríguez Faba Ó, et al. Among authors: guerrero ramos f. Actas Urol Esp (Engl Ed). 2024 Dec;48(10):718-731. doi: 10.1016/j.acuroe.2024.09.005. Epub 2024 Sep 26. Actas Urol Esp (Engl Ed). 2024. PMID: 39341566 English, Spanish.
Epidemiology, Diagnosis and Management of Penile Cancer: Results from the Spanish National Registry of Penile Cancer.
Borque-Fernando Á, Gaya JM, Esteban-Escaño LM, Gómez-Rivas J, García-Baquero R, Agreda-Castañeda F, Gallioli A, Verri P, Ortiz-Vico FJ, Amir-Nicolau BF, Osman-Garcia I, Gil-Martínez P, Arrabal-Martín M, Gómez-Ferrer Lozano Á, Campos-Juanatey F, Guerrero-Ramos F, Rubio-Briones J; Grupo Cooperativo de Registro Nacional Cáncer Pene (PIEM/AEU/2014/0002). Borque-Fernando Á, et al. Cancers (Basel). 2023 Jan 19;15(3):616. doi: 10.3390/cancers15030616. Cancers (Basel). 2023. PMID: 36765574 Free PMC article.
A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-E.
Tan WP, Plata Bello A, Garcia Alvarez C, Guerrero-Ramos F, González-Padilla DA, Nzeh C, Manuel de la Morena J, de Torres IGV, Hendricksen K, Díaz Goizueta FJ, Del Álamo JF, Chiancone F, Fedelini P, Poggio M, Porpiglia F, Gonzalo Rodríguez VC, Torres JM, Wilby D, Robinson R, Sousa-Escandón A, Mata JL, Pontones Moreno JL, Molina FD, Adriazola Semino MA, Stemberger AT, Escudero JC, Redorta JP, Tan WS. Tan WP, et al. Bladder Cancer. 2022 Dec 14;8(4):379-393. doi: 10.3233/BLC-220026. eCollection 2022. Bladder Cancer. 2022. PMID: 38994184 Free PMC article.
59 results